C4 Therapeutics, Inc. (NASDAQ:CCCC) is included in our list of the 7 most volatile stocks under $5 for day trading. As of ...
LISBON, Portugal, Nov. 11, 2025 /PRNewswire/ -- Crypto Content Creator Campus (CCCC), the global summit at the intersection of content, crypto, and creator monetization, today announced the ...
C4 Therapeutics Inc. (NASDAQ:CCCC) is one of the best biotech penny stocks to buy according to analysts. On December 17, Barclays lowered the firm’s price target on C4 Therapeutics to $5 from $10, ...
The Crypto Content Creator Campus (CCCC) welcomes a powerhouse lineup of additional sponsors as it gears up for its inaugural event in Dubai this November. This second wave of support underscores the ...
The Crypto Content Creator Campus (CCCC) 2025 wrapped up a successful, sold-out three-day event in Lisbon, Portugal, from November 14 to 16, 2025. Hosted at the iconic Carlos Lopes Pavilion , the ...
Fintel reports that on December 19, 2024, Wells Fargo upgraded their outlook for C4 Therapeutics (NasdaqGS:CCCC) from Equal-Weight to Overweight. As of December 3, 2024, the average one-year price ...
The average one-year price target for C4 Therapeutics (NasdaqGS:CCCC) has been revised to $10.05 / share. This is a decrease of 13.75% from the prior estimate of $11.66 dated January 11, 2026. The ...
The Crypto Content Creator Campus (CCCC) 2025, supported by title sponsor Bybit, held its Lisbon 2025 Calling event earlier this month in Lisbon, Portugal. Under the theme “Monetization in the Web3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results